SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9670Does this have any relevant meaning for us? Intellect Neurosciences, Inc. Grantsteve kammerer-5/19/2008
9669FYI- [t]ELN[/t] Just got this in my email schaeffersresearch.com 73, BenBen Antanaitis-5/14/2008
9668Echoing Fred's, I'm sure all of our prayers are with yours for your wifequidditch-5/13/2008
9667IJ, that's very good news. And not because I own ELN -- it's just plainfred hayes-5/13/2008
9666Over the years I have followed Tysabri and ELN partly out of an investment interIRWIN JAMES FRANKEL-5/13/2008
9665Are you still holding a position, Bob ? - eomQualified Opinion-5/7/2008
9664thanks for the reminder. I didn't realize it started so early. I'm goifred hayes-5/7/2008
9663Elan's Company Day is tomorrow; 7 May... The theme is "Bringing Sciencepgo-neil-5/7/2008
9662Thanks for bringing that over, and thanks to Stillorgan for the work. For those fred hayes-5/4/2008
9661FTY720, a novel oral therapy in development for MS, shows sustained benefits forQualified Opinion-5/4/2008
9660TexasDude you asked about FTY-720 Question [21]: Can I sneak in a couple of quedavid staton-5/4/2008
9659ELAN CEO Kelly Martin presentation at Morgan Stanley Global Healthcare. Thanks david staton-5/4/2008
9658Copaxone just had a blowout sales quarter, FWIW: siliconinvestor.com Regards, DewDiligence_on_SI-4/30/2008
9657You are right...the cult following is a little scary, especially looking at the Arthur Radley-4/30/2008
9656per WYE cc, they have requested FDA permission to restart ACC 001 trial. Incidefred hayes-4/30/2008
9655Adam has a hard-on for the ELN cult so tends to focus on ELN. Probably not totaRobohogs-4/30/2008
9654From Adam Feuerstein's column today....appears he is nitpicking about what EArthur Radley-4/30/2008
9653Yes, I would bet on those discussions. My initial thot was that Euro regulatorsfred hayes-4/28/2008
965295% of biotechs go bankrupt again...good luck finding the pearls..Staranalyst88-4/28/2008
9651Wouldn't you expect that the agency either has had the private discussion onBiotech Jim-4/28/2008
9650BJ, the endpoints are different than the previous P3 if I'm tracking correctfred hayes-4/28/2008
9649Jim, Thanks for the reply! That is how I interpreted the report, but was afraid Arthur Radley-4/28/2008
9648Wyeth at Clintrials.gov has now reported on a ex US AD trial with bapineuzumab. Biotech Jim-4/28/2008
9647The parts of the document most worthy of a read are parts 9 and 10, those dealinBiotech Jim-4/28/2008
9646They cannot get around it as they will collect data both ways from what I undersRobohogs-4/27/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News